A Controlled Multi-Arm Ph1 Study Evaluating the Safety and Feasibility of TCR Engineered Donor TCells Targeting HA1 (TSC-100) or HA2 (TSC-101) in HLA-A0201 Positive Patients Undergoing Haploidentical Allogeneic Stem Cell Transplantation Read more
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel Read more
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel Read more
Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release Read more
Post-Transplant Chimerism Patterns in Patients with Myelodysplastic Syndromes and Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation at the John Theurer Cancer Center Read more
Dynamic Changes in Pre- and Post-Transplant NGS MRD Status For Prediction of the Allogeneic Stem Cell Transplant Outcome in Patients with AML Read more
